The PE Ratio as of December 2025 (TTM) for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) is 26.00

According to Zhongzhi Pharmaceutical Holdings Limited’s latest financial reports and current stock price. The company's current PE Ratio is 26.00. This represents a change of 105.36% compared to the average of 12.66 of the last 4 quarters.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Historical PE Ratio (quarterly & annually)

How has 3737.HK PE Ratio performed in the past?

The mean historical PE Ratio of Zhongzhi Pharmaceutical Holdings Limited over the last ten years is 11.79. The current 26.00 PE Ratio has changed 21.96% with respect to the historical average. Over the past ten years (40 quarters), 3737.HK's PE Ratio was at its highest in in the June 2025 quarter at 20.07. The PE Ratio was at its lowest in in the December 2021 quarter at -10.21.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zhongzhi Pharmaceutical Holdings Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) Average PE Ratio

How has 3737.HK PE Ratio performed in the past?

The current PE Ratio of Zhongzhi Pharmaceutical Holdings Limited (3737.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) PE Ratio vs. Peers

How is 3737.HK’s PE Ratio compared to its peers?

Zhongzhi Pharmaceutical Holdings Limited’s PE Ratio is greater than Wai Yuen Tong Medicine Holdings Limited (-33.36), greater than China NT Pharma Group Company Limited (-5.98), greater than Modern Chinese Medicine Group Co., Ltd. (15.43), greater than Fusen Pharmaceutical Company Limited (-2.86), greater than MOG Holdings Limited (-3.48), greater than Austar Lifesciences Limited (12.37), greater than Vincent Medical Holdings Limited (6.10), greater than Charmacy Pharmaceutical Co., Ltd. (10.37), greater than Yunkang Group Limited (-0.72), greater than Kato (Hong Kong) Holdings Limited (19.40),

Build a custom stock screener for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhongzhi Pharmaceutical Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhongzhi Pharmaceutical Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.